Cohance Lifesciences said that the United States Food and Drug Administration (US FDA), post an inspection, has issued a Form FDA 483 with four observations to the company’s formulation (FDF) plant located at Telangana.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.